IL168810A - Pulverulent formulation for inhalation containing tiotropium - Google Patents

Pulverulent formulation for inhalation containing tiotropium

Info

Publication number
IL168810A
IL168810A IL168810A IL16881005A IL168810A IL 168810 A IL168810 A IL 168810A IL 168810 A IL168810 A IL 168810A IL 16881005 A IL16881005 A IL 16881005A IL 168810 A IL168810 A IL 168810A
Authority
IL
Israel
Prior art keywords
containing tiotropium
inhalation containing
pulverulent formulation
pulverulent
formulation
Prior art date
Application number
IL168810A
Other languages
Hebrew (he)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL168810(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL168810A publication Critical patent/IL168810A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL168810A 2002-11-28 2005-05-26 Pulverulent formulation for inhalation containing tiotropium IL168810A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255387A DE10255387A1 (en) 2002-11-28 2002-11-28 New tiotropium-containing powder formulation for inhalation
PCT/EP2003/012911 WO2004047796A2 (en) 2002-11-28 2003-11-19 Pulverulent formulation for inhalation containing tiotropium

Publications (1)

Publication Number Publication Date
IL168810A true IL168810A (en) 2015-02-26

Family

ID=32308760

Family Applications (1)

Application Number Title Priority Date Filing Date
IL168810A IL168810A (en) 2002-11-28 2005-05-26 Pulverulent formulation for inhalation containing tiotropium

Country Status (34)

Country Link
EP (1) EP1567135B1 (en)
JP (1) JP4977321B2 (en)
KR (1) KR101066805B1 (en)
CN (1) CN100574751C (en)
AR (1) AR042242A1 (en)
AT (1) ATE401861T1 (en)
AU (1) AU2003294714B2 (en)
BR (1) BR0316343A (en)
CA (1) CA2507579C (en)
CO (1) CO5580736A2 (en)
CY (1) CY1108420T1 (en)
DE (2) DE10255387A1 (en)
DK (1) DK1567135T3 (en)
EA (1) EA011549B1 (en)
EC (1) ECSP055821A (en)
ES (1) ES2310681T3 (en)
HK (1) HK1085918A1 (en)
HR (1) HRP20050468A2 (en)
IL (1) IL168810A (en)
ME (1) MEP51608A (en)
MX (1) MXPA05005485A (en)
MY (1) MY140890A (en)
NO (1) NO20053090D0 (en)
PE (1) PE20040848A1 (en)
PL (1) PL376229A1 (en)
PT (1) PT1567135E (en)
RS (1) RS20050400A (en)
SA (1) SA04240467B1 (en)
SI (1) SI1567135T1 (en)
TW (1) TWI332837B (en)
UA (1) UA81930C2 (en)
UY (1) UY28096A1 (en)
WO (1) WO2004047796A2 (en)
ZA (1) ZA200502859B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016904A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
DE102008014025A1 (en) * 2008-03-13 2009-09-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaler and strainer for an inhaler
TR200909788A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Dry powder formulation suitable for inhalation with tiotropium
KR101805958B1 (en) * 2010-08-03 2017-12-07 키에시 파르마슈티시 엣스. 피. 에이. Dry powder formulation comprising a phophodiesterase inhibitor
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
KR101748796B1 (en) * 2015-09-30 2017-06-19 한미약품 주식회사 Inhalation capsule with enhanced delivery rate of active ingredients
KR101728116B1 (en) * 2015-11-03 2017-04-18 한미약품 주식회사 Dry powder composition for inhalation comprising tiotropium or pharmaceutically acceptable salt thereof
CN111514418B (en) * 2019-06-12 2022-01-14 中南大学湘雅二医院 Self-suction nasal powder material feeding device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE4140689B4 (en) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalable powders and process for their preparation
DE4318455A1 (en) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Capsule holder
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (en) * 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation application
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
KR100488644B1 (en) * 2000-10-12 2005-05-11 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 Novel tiotropium-containing inhalation powder
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
DE10141377A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Scattering process for the production of powder formulations
ATE339951T1 (en) * 2002-04-04 2006-10-15 Boehringer Ingelheim Pharma POWDER PREPARATIONS FOR INHALATION
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium

Also Published As

Publication number Publication date
UY28096A1 (en) 2004-06-30
ES2310681T3 (en) 2009-01-16
DE10255387A1 (en) 2004-06-09
DK1567135T3 (en) 2008-10-27
SA04240467B1 (en) 2008-10-15
JP4977321B2 (en) 2012-07-18
EP1567135B1 (en) 2008-07-23
EA200500864A1 (en) 2006-02-24
NO20053090L (en) 2005-06-23
HK1085918A1 (en) 2006-09-08
AR042242A1 (en) 2005-06-15
CO5580736A2 (en) 2005-11-30
PE20040848A1 (en) 2005-01-14
PL376229A1 (en) 2005-12-27
WO2004047796A2 (en) 2004-06-10
AU2003294714A1 (en) 2004-06-18
KR20050086887A (en) 2005-08-30
SI1567135T1 (en) 2008-10-31
CN1717225A (en) 2006-01-04
RS20050400A (en) 2007-04-10
UA81930C2 (en) 2008-02-25
JP2006510622A (en) 2006-03-30
ATE401861T1 (en) 2008-08-15
BR0316343A (en) 2005-09-27
ZA200502859B (en) 2006-02-22
CN100574751C (en) 2009-12-30
DE50310208D1 (en) 2008-09-04
MEP51608A (en) 2011-02-10
CY1108420T1 (en) 2014-04-09
MY140890A (en) 2010-01-29
EA011549B1 (en) 2009-04-28
PT1567135E (en) 2008-09-01
MXPA05005485A (en) 2005-07-25
EP1567135A2 (en) 2005-08-31
WO2004047796A3 (en) 2004-09-30
AU2003294714B2 (en) 2009-10-08
ECSP055821A (en) 2005-08-11
TW200500066A (en) 2005-01-01
CA2507579A1 (en) 2004-06-10
CA2507579C (en) 2011-07-19
NO20053090D0 (en) 2005-06-23
HRP20050468A2 (en) 2006-07-31
TWI332837B (en) 2010-11-11
KR101066805B1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
IL174496A0 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
EG24456A (en) Powder inhaler
EP1635762A4 (en) Low dose pharmaceutical powders for inhalation
ZA200503546B (en) Tiotropium containing HFC solution formulations
AU2003244650A8 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
IL161446A0 (en) Medicinal compositions for nasal absorption
HK1085918A1 (en) Pulverulent formulation for inhalation containing tiotropium
EP1504780A4 (en) Powder chemical feeding device for nasal cavity
HK1078793A1 (en) Aerosol formulation for inhalation comprising a tiotropium salt
HK1129111A1 (en) Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof
AU300689S (en) Powder inhalator
AU2003267809A8 (en) Powder inhaler
GB0228305D0 (en) Therapeutic composition for respiratory delivery
EP1484061A4 (en) Drugs containing riboflavin-type compounds
AU2003264443A8 (en) Preparation for external use
GB0226274D0 (en) Metered dose inhalation preparations
GB0124010D0 (en) Pharmaceutical compositions for inhalation
GB0127359D0 (en) Pharmaceutical compositions for inhalation
GB0226830D0 (en) Composition for use as a medicament
GB0209482D0 (en) Medicinal compounds
GB0220729D0 (en) Medicinal compounds
GB0215930D0 (en) Medicinal compounds
GB0224498D0 (en) Medicinal compounds
GB0224494D0 (en) Medicinal compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees